|
|
|
|
AR 2007 Lo Res.pdf page 70
|
|
|
AR 2007 Lo Res.pdf page 69
|
|
|
untitled page 115
|
|
|
untitled page 62
|
|
|
untitled page 53
|
|
|
untitled page 47
|
|
|
PAR-2023-1-DZ.1-563854-PrepressPdfNoBL.pdf page 92
author: Asura
|
|
|
PAR-2023-1-DZ.1-563854-PrepressPdfNoBL.pdf page 40
author: Asura
|
|
|
PAR-2023-1-DZ.1-563854-PrepressPdfNoBL.pdf page 31
author: Asura
|
|
|
PAR-2023-1-DZ.1-563854-PrepressPdfNoBL.pdf page 25
author: Asura
|
|
|
Oral antihistamines for atopic dermatitis - [Medication] - Quest Diagnostics Patient Health Library
Oral antihistamines for atopic dermatitis Examples Brand Name Chemical Name Benadryl diphenhydramine hydrochloride Atarax, Marax, Marax-DF hydroxyzine Optimine, Trinalin Repetabs azatadine maleate Zyrtec cetirizine hydrochloride [less sedating] Claritin loratadine [nonsedating] Allegra fexofenadine [nonsedating] How It Works Antihistamines reduce itching by blocking...
|
|
|
Antihistamines for allergic rhinitis - [Medication] - Quest Diagnostics Patient Health Library
Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About Antihistamines for allergic rhinitis - [Medication] - Quest Diagnostics Patient Health Library Antihistamines for allergic rhinitis - [Medication] - Quest Diagnostics Patient Health Library acrivastine, Alavert, Allegra, Allergic, allergic disorder, Allergies, Allergy,...
|
|
|
cov0351.qxd
week 0351 19 Dec 2003 Sumika claims a synthesis of 4'bromomethyl- 2- cyanobiphenyl, a key intermediate for losartan- type angiotensin II antagonists such as irbesartan (left), which is also the subject of a refreshing candid and detailed critique from Dr Bertrand Castro of Sanofi- Synthelabo (See Highlights) Drug Patenting in Context This issue of Current Patents Gazette is the final...
author: MSparrowhawk
|
|
|
PDF cover 0438.qxd
DOLPHIN Current Patents Gazette Patenting in Context News & Highlights from Week 0438 The records appearing in this Gazette will be added to DOLPHIN, the database Of all pharmaceutical inventions in the next week.
Hoffman La Roche and their associated subsidiary companies were very active this month with Roche gaining 5 years protection on the product patent for granisteron, which...
author: LEmson
|
|
|
Gazette Highlights News 2003 - Thomson Scientific
Thomson.com - - - - - Advanced Search - - - EN : JP : CN : KR -- - - Thomson Scientific : Gazette Weekly Highlights News : Gazette Highlights News 2003 - Gazette Highlights News 2003 Click on a week to view more Week 51: This issue of Current Patents Gazette is the final one for 2003...
Week 42: The grant of a Supplementary Protection Certificate (SPC) to Pentech is among eight...
|
|
|
Cover 0517.qxd
The UK PDJ this week records the expiry on April 1, 2005 of the SPC granted to Merrell Pharmaceuticals (now SanofiAventis) for fexofenadine, an Aventis antihistaminic drug sold under the tradename Allegra ®.
Also announced recently was the news that Barr Pharmaceticals had been granted approval for their generic version of Aventis' Allegra- D ® 12 hour extended...
author: GWhite
|
|
|
Cover 0517.qxd page 1
author: GWhite
|
|
|
Gazette Weekly Highlights News - Thomson Scientific
Thomson.com - - - - - Advanced Search - - - EN : JP : CN : KR -- - - - Current Patents Gazette - Weekly Highlights News The gazette weekly highlights focuses on patent-related issues making the headlines, on noteworthy new applications, and on litigation and legislation affecting the industry.
UK initial (“A0”) applications filed May 13th - May 19th 2005 Week 24: This...
|
|
|
untitled
Dermatology Challenge c l e a r i n g u p c o m p l e x c a s e s Self- mutilation and over- grooming in a Siamese cat Karen A.
Previous therapies included paroxetine hydrochloride (1 mg/ kg once a day) for three months and feline pheromones (FeliwayN Ceva Sante Animale) for one month, to which no responses had been noted; the cat had continued to over- groom.
Note the...
|
|
|
untitled page 3
|
|
|
Sepracor
Press | Search | Glossary | Terms & Conditions -- Sepracor Sepracor Sepracor, Sepracor Inc., SEPR, Soltara, Xopenex, Estorra, pharmaceutical, pharmaceuticals, levalbuterol, tecastemizole, Estorra, esopiclone, eszopiclone, amlodipine, allergies, asthma, antihistamine, COPD, chronic obstructive pulmonary disease, sleep disorders, insomnia, transient insomnia, chronic insomnia, urinary...
|
|
|
Sepracor
Press | Search | Glossary | Terms & Conditions -- Sepracor Sepracor Sepracor, Sepracor Inc., SEPR, Soltara, Xopenex, Estorra, pharmaceutical, pharmaceuticals, levalbuterol, tecastemizole, Estorra, esopiclone, eszopiclone, amlodipine, allergies, asthma, antihistamine, COPD, chronic obstructive pulmonary disease, sleep disorders, insomnia, transient insomnia, chronic insomnia, urinary...
|
|
|
Sepracor - About Sepracor
Home / About Sepracor / Corporate Agreements History Leadership Corporate Agreements ---- Partners Chart Corporate Agreements ACADIA Pharmaceuticals INC.
Sepracor is credited with all sales and Abbott receives a commission on pediatric sales.
Subject to the successful completion of the proposed business combination between Aventis and Sanofi-Synthelabo, Sepracor and sanofi...
|
|
|
Drug Approvals - A
NDA 14-691/S-020 5/24/01 11/21/02 7/5/03 Allegra (fexofenadine hydrochloride) Capsules 60 mg
NDA 20- 625 7/25/96 - 4/30/03 - Allegra (fexofenadine hydrochloride) Capsules and Tablets, 30, 60, and 180 mg
NDA 20-872 2/25/00 2/29/00 2/29/00 2/19/02 Allegra (Fexofenadine HCI) Tablets Aventis Pharmaceuticals NDA 20-872/S1, 2 & 4 10/29/01 11/8/01 - 11/8...
|
|
|
What's new at CDER by Date
Zometa (zoledronic acid) Injection, Novartis Pharmaceuticals Fexofenadine HCI & Pseudoephedrine HCI Extended-Release Tablets, Impax Laboratories, Tentative Approval News Along the Pike; January-February 2004 [ HTML ] or [ PDF ] Orange Book Query Warning Letters and Notice of Violation Letters to Pharmaceutical Companies February 26, 2004 Drug Shortages; Resolved: Amytal ...
author: Paul Stauffer
|
